The single market and pharmaceutical industry in the European Union: Is there any evidence of price convergence?
During the last two decades, the European Union (EU) has experienced closer market integration through the removal of trade barriers, the establishment of a single market, and the reduction of exchange rate volatility. In addition, there have been several structural reforms in product markets design...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholar Commons
2006
|
| Subjects: | |
| Online Access: | http://scholarcommons.usf.edu/etd/2728 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=3727&context=etd |